T cell kymriah for patients at nashville VAMC
Ended Awarded Last action
- Contract number
- 36C24920N0594
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $283,527
Award facts
- Contract value 100% obligated
- $283,526.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $283,527 |
About this award
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs Veterans Health Administration to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer, to provide the Kymriah chimeric antigen receptor T-cell therapy to the Nashville VA Medical Center. The order, valued at $283,526.57, was issued against Novartis' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which has a total potential value of $5.4 billion. Kymriah is a specialized cell therapy used to treat certain types of cancer, and this delivery order will facilitate treatment for veterans. The contract had no set-aside designation.
Quick answers
Who was awarded contract 36C24920N0594?
36C24920N0594 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 9 (Veterans Health Administration) on July 15, 2020.
How much is contract 36C24920N0594 worth?
The government has obligated $283,527 on 36C24920N0594.
Is contract 36C24920N0594 an order under another contract?
Yes. 36C24920N0594 is a delivery order under V797D30268, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24920N0594 competed?
The extent of competition for 36C24920N0594 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award